SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Traders are linking QNTs sharp rally to a reported Clearing House initiative involving Quant and on-chain banking, alongside interest in the projects institutional adoption prospects and limited token supply. Bulls see those themes supporting further repricing, while skeptics call the move speculative and warn of a pullback.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEARs rally and new one-year high are being linked by traders to Bitwises spot NEAR ETF receiving approval to list on NYSE Arca, with some also citing the prospectus filing as a source of excitement about potential institutional access. Sentiment is largely bullish, though some traders warn of a pullback or describe the move as vulnerable to profit-taking.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JASMY is rallying as traders react to Panasonic Advanced Technologys announced work with Jasmy and JANCTION on a distributed-GPU rendering product, which the community sees as evidence of real-world development. Bulls view it as a potential adoption signal, while some traders caution that direct demand for the JASMY token has not been established and remain concerned about exchange delistings.

Cronos is an institutional-grade, high-performance, EVM-compatible Layer-1 blockchain built on the Cosmos SDK and integrated with the Inter-Blockchain Communication (IBC) protocol, designed as the backbone for open, compliant, and AI-accessible tokenized markets. It supports up to 60,000 transactions per second (TPS), 500ms block times, instant finality, and sub-$0.01 fees via Proof of Authority consensus.

Crypto.com Coin

CROs price swings have reignited debate over its large token supply and the return of previously burned tokens, which many traders see as persistent dilution and a drag on performance. Some are encouraged by brief rebounds and Crypto.com developments, while skeptics expect gains to fade amid continued selling pressure.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Attention centers on the upcoming Phase 3 EMT-2 colorectal cancer results, scheduled for a late-breaking presentation at ESMO; traders note that the presentation slot does not signal a positive result and that efficacy data have not been disclosed. The community debates whether favorable results could add strategic value, while concerns about monetizing Vascepa amid generic competition and uncertainty over the LR-EtEPA patent temper buyout speculation.

|The Artificial Superintelligence (ASI) Alliance is the world’s largest open-source initiative dedicated to decentralized Artificial General Intelligence (AGI). Formed in April 2024, the ASI Alliance unites SingularityNET, Fetch.ai, and Ocean Protocol, with CUDOS joining as a network member shortly after. The ASI Alliance was established through a community-approved tokenomic merger—combining $AGIX, $FET, and $OCEAN into a single token: $FET. This unified token underpins a collaborative framework designed to scale open-source AI and stand as the largest open-sourced, independent entity in AI research and development. The Alliance is committed to accelerating the advancement of decentralized Artificial General Intelligence (AGI) and, ultimately, Artificial Superintelligence (ASI). It provides a robust, open-source innovation stack, empowering developers, enterprises, and researchers globally to build ethical, scalable, and groundbreaking AI solutions. This ensures that advanced intelligence remains a shared, accessible resource, fostering innovation beyond centralized systems and promoting a future where AI benefits all.

Fetch.ai

FET is drawing attention after a strong rebound that traders frame as a breakout and renewed rotation into AI-focused crypto, particularly autonomous-agent projects. Bullish traders point to Fetch/ASI product development, while skeptics question whether the move can hold through resistance and broader Bitcoin weakness.

Aerodrome Finance is a next-generation AMM designed to serve as Base's central liquidity hub, combining a powerful liquidity incentive engine, vote-lock governance model, and friendly user experience. Aerodrome inherits the latest features from Velodrome V2.

Aerodrome Finance

Traders are focused on Aerodromes planned merger with Velodrome and expansion into Ethereum and other networks, which they see as a potential shift from a Base-focused DEX to broader cross-chain liquidity infrastructure. Many are bullish on the rollout and token buybacks, while others question the price action and point to delays and ongoing token emissions as risks.

Pump.fun

PUMP is drawing attention after a sharp rebound, with traders pointing to bullish chart momentum, platform buybacks and renewed Solana memecoin activity as possible support. Others remain skeptical, describing the move as a pump-and-dump and raising concerns about volatility and token supply.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS is drawing attention for a technical rebound after an eight-session losing streak, with traders describing the shares as oversold and pointing to bullish chart patterns. Bullish comments also cite the companys strong Q2 results and raised 2026 outlook, while some investors remain cautious about whether the rebound can hold.

Quantinuum Inc. is a quantum computing platform that offers solutions like hardware platforms, developer tools, application libraries and solution-targeted intellectual property (“IP”). The company was founded on January 20, 2026 and is headquartered in Broomfield, CO.

Quantinuum Inc. - Ordinary Shares - Class A

Quantinuum Inc.

Quantinuums finalized $100 million CHIPS R&D award is drawing attention, with traders also citing its expected Russell index additions and commercial partnerships. Reactions are split between optimism about government backing and concerns that the companys valuation is high relative to its current revenue.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$RARE 🤡 people complain about this company’s cash position and then complain why they pay in stock and not cash. And have no idea how they retain the best people 😅... and failed to read the corporate charter or meeting minutes AND complain when the board acts on those decisions 🤡 . Nice try clown.

EspírituDeRiesgo

Rahul Gando

Fadi

$RARE a company with 5 bln revenue only gave $250 mln in bonus. How fishy a 670 mln revenue gave $200 mln in bonus.

StockTwits for iOS

Ultragenyx Pharmaceutical Inc

john

StockTwits For Android 

 🤡 people complain about this company’s cash position and then complain why they pay in stock and not cash. And have no idea how they retain the best people 😅... and failed to read the corporate charter or meeting minutes AND complain when the board acts on those decisions 🤡 . Nice try clown.

Vince

@LouKojak do you know the reason it dropped none stop from $140 to $14 then no squeeze after ux111 got approved? Bag holders can dream big and want to ignore the reality checks. Those are fking facts not complaining. They are fking over spent to themselves.

 do you know the reason it dropped none stop from $140 to $14 then no squeeze after ux111 got approved? Bag holders can dream big and want to ignore the reality checks. Those are fking facts not complaining. They are fking over spent to themselves.

@LouKojak take $INCY for an example, they have double employees of rare but bonuses are the same at $200 mln. Also incy has 20x market cap as well as revenue. You can keep your points and all in. They will eat your alive.

Incyte Corp.

 for an example, they have double employees of rare but bonuses are the same at $200 mln. Also incy has 20x market cap as well as revenue. You can keep your points and all in. They will eat your alive.

@rong22003 then why are you here? As to why things happen, if you actually knew, you&#39;d be so rich that posting here would be a complete waste of your time 🤡

 then why are you here? As to why things happen, if you actually knew, you'd be so rich that posting here would be a complete waste of your time 🤡

@LouKojak i am here to short. Keep dreaming about your squeeze.

 i am here to short. Keep dreaming about your squeeze.

@rong22003 i have a squeeze? 🍋🍋🍋😅 wtf are you talking about?

 i have a squeeze? 🍋🍋🍋😅 wtf are you talking about?